J7644 HCPCS code: Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram

J7644 is the HCPCS Level II code for ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram. In 2024 Medicare paid an average of $0.23 per service for J7644 across 15,115 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 279 per day on DME suppliers. Medicare volume rose 4% from 2022 to 2024 (14,585 to 15,115 services). In 2024, 10,940 suppliers billed Medicare for J7644 (purchases), serving 21,438 beneficiaries; Texas, California, Florida accounted for 25% of services.

Code details

Who bills J7644 (2024)

Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.

Medicare utilization for J7644, 2022–2024

States with the most J7644 services (2024)

NCCI unit limits (MUE)

Medicare policy articles for this code

• A52466: Nebulizers - Policy Article (CGS Administrators, LLC (DME MAC) Noridian Healthcare Solutions, LLC (DME MAC)) — mentions this code in its coding guidance

Covered diagnoses (215 ICD-10-CM codes)

The diagnoses most often listed as covered in the policy articles above:

Showing 10 of 215. The full list, non-covered diagnoses and CSV export are in Caduvo.

What changed for J7644

• 2000-01-01: J7644 added to HCPCS Level II
• Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01

Frequently asked questions

What is HCPCS code J7644?

J7644 is the HCPCS Level II code for ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram. Short descriptor: "Ipratropium bromide non-comp".

How much does Medicare pay for J7644?

In 2024, the average Medicare payment was $0.23 per service (average allowed $0.33).

Does Medicare cover J7644?

Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.

Which diagnoses support coverage for J7644?

Medicare policy articles that cite J7644 list 215 covered ICD-10-CM diagnosis codes across 1 article. The most cited include A15.0 (Tuberculosis of lung), A22.1 (Pulmonary anthrax), A37.01 (Whooping cough due to Bordetella pertussis with pneumonia). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.

How many units of J7644 can be billed per day?

279 on DME suppliers; 3 on practitioner claims (NCCI medically unlikely edits).

Related J76 codes

• J7601 — Ensifentrine, inhalation suspension, fda approved final product, non-compounded, administered through dme, unit dose form, 3 mg
• J7604 — Acetylcysteine, inhalation solution, compounded product, administered through dme, unit dose form, per gram
• J7605 — Arformoterol, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 15 micrograms
• J7606 — Formoterol fumarate, inhalation solution, fda approved final product, non-compounded, administered through dme, unit dose form, 20 micrograms
• J7607 — Levalbuterol, inhalation solution, compounded product, administered through dme, concentrated form, 0.5 mg
• J7608 — Acetylcysteine, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per gram
• J7609 — Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg
• J7610 — Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg
• J7611 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg
• J7612 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
• J7613 — Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg
• J7614 — Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg

Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.

Next steps

• Run a reimbursement report for a device billed under J7644
• Watch J7644 for fee, coverage and descriptor changes
• Build a full Medicare revenue model for J7644

Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.

All J codes · HCPCS lookup